Patents by Inventor Suvit Thaisrivongs

Suvit Thaisrivongs has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 4-Oxo-4,7-dihydrothieno[2,3-b]pyridine-5-carboxamides as antiviral agents
    Patent number: 6831081
    Abstract: The present invention provides a compound of formula as described herein, which are useful as antiviral agents, in particular, as agents against viruses of the herpes family.
    Type: Grant
    Filed: August 27, 2003
    Date of Patent: December 14, 2004
    Assignee: Pharmacia & Upjohn
    Inventors: Mark E. Schnute, Fred L. Ciske, Michael J. Genin, Joseph Walter Strohbach, Suvit Thaisrivongs
  • 4-Oxo-4,7-dihydrothieno[2,3-b]pyridine-5-carboxamides as antiviral agents
    Publication number: 20040110786
    Abstract: The present invention provides a compound of formula as described herein, which are useful as antiviral agents, in particular, as agents against viruses of the herpes family.
    Type: Application
    Filed: August 27, 2003
    Publication date: June 10, 2004
    Inventors: Mark E. Schnute, Fred L. Ciske, Michael J. Genin, Joseph Walter Strohbach, Suvit Thaisrivongs
  • Heterocycle carboxamides as antiviral agents
    Publication number: 20040029879
    Abstract: The present invention provides a compound of formula I 1
    Type: Application
    Filed: July 31, 2003
    Publication date: February 12, 2004
    Inventors: David John Anderson, Thomas J. Beauchamp, Gordon L. Bundy, Fred L. Ciske, John R. Farrell, David R. Graber, Michael J. Genin, Thomas M. Judge, Malcolm Wilson Moon, Mark E. Schnute, Joseph Walter Strohbach, Suvit Thaisrivongs, Atli Thorarensen, Steven Ronald Turner, Valerie A. Vaillancourt, Allison J. Wolf
  • Oxazinoquinolones useful for the treatment of viral infections
    Patent number: 6673793
    Abstract: The present invention provides a compound of formula I which is useful as antiviral agents, in particular, as agents against viruses of the herpes family.
    Type: Grant
    Filed: June 28, 2001
    Date of Patent: January 6, 2004
    Assignee: Pharmacia & Upjohn Co.
    Inventors: Steven Ronald Turner, Suvit Thaisrivongs, Atli Thorarensen
  • Heterocycle carboxamides as antiviral agents
    Patent number: 6624159
    Abstract: The present invention provides a compound of formula I which is useful as antiviral agents, in particular, as agents against viruses of the herpes family.
    Type: Grant
    Filed: June 22, 2001
    Date of Patent: September 23, 2003
    Assignee: Pharmacia & Upjohn Company
    Inventors: David John Anderson, Gordon L. Bundy, Fred L. Ciske, David R. Graber, Michael J. Genin, Thomas M. Judge, Malcolm Wilson Moon, Mark E. Schnute, Joseph Walter Strohbach, Suvit Thaisrivongs, Atli Thorarensen, Steven Ronald Turner, Valerie A. Vaillancourt, Allison J. Wolf
  • 8-hydroxy-7-substituted quinolines as anti-viral agents
    Patent number: 6500842
    Abstract: The present invention provides for 8-hydroxy-7-substituted quinoline compounds such as formula IA These compounds are useful as anti-viral agents. Specifically, these compounds have anti-viral activity against the herpes virus, cytomegalovirus (CMV). Many of these compounds are also active against other herpes viruses, such as the varicella zoster virus, the Epstein-Barr virus, the herpes simplex virus and the human herpes virus type 8 (HHV-8).
    Type: Grant
    Filed: October 23, 2001
    Date of Patent: December 31, 2002
    Assignee: Pharmacia & Upjohn Company
    Inventors: Valerie Ann Vaillancourt, Joseph Walter Strohbach, Olivier Bezencon, Suvit Thaisrivongs
  • Oxazinoquinolones useful for the treatment of viral infections
    Publication number: 20020103170
    Abstract: The present invention provides a compound of formula I 1
    Type: Application
    Filed: June 28, 2001
    Publication date: August 1, 2002
    Inventors: Steven Ronald Turner, Suvit Thaisrivongs, Atli Thorarensen
  • Heterocycle carboxamides as antiviral agents
    Publication number: 20020025959
    Abstract: The present invention provides a compound of formula I 1
    Type: Application
    Filed: June 22, 2001
    Publication date: February 28, 2002
    Inventors: David John Anderson, Thomas J. Beauchamp, Gordon L. Bundy, Fred L. Ciske, John R. Farrell, David R. Graber, Michael J. Genin, Thomas M. Judge, Malcolm Wilson Moon, Mark E. Schnute, Joseph Walter Strohbach, Suvit Thaisrivongs, Atli Thorarensen, Steven Robert Turner, Valerie A. Vaillancourt, Allison J. Wolf
  • Oxazinoquinolones useful for the treatment of viral infections
    Patent number: 6340680
    Abstract: The present invention provides a compound of formula I These compounds are useful as antiviral agents, in particular, as agents against viruses of the herpes family.
    Type: Grant
    Filed: September 28, 2000
    Date of Patent: January 22, 2002
    Assignee: Pharmacia and Upjohn Company
    Inventors: Steven Ronald Turner, Suvit Thaisrivongs
  • 8-hydroxy-7-substituted quinolines as anti-viral agents
    Patent number: 6310211
    Abstract: The present invention provides for 8-hydroxy-7-substituted quinoline compounds such as formula IA These compounds are useful as anti-viral agents. Specifically, these compounds have anti-viral activity against the herpes virus, cytomegalovirus (CMV). Many of these compounds are also active against other herpes viruses, such as the varicella zoster virus, the Epstein-Barr virus, the herpes simplex virus and the human herpes virus type 8 (HHV-8).
    Type: Grant
    Filed: September 5, 1997
    Date of Patent: October 30, 2001
    Assignee: Pharmacia & Upjohn Company
    Inventors: Valerie Ann Vaillancourt, Karen Rene Romines, Arthur Glenn Romero, John Alan Tucker, Joseph Walter Strohbach, Olivier Bezencon, Suvit Thaisrivongs
  • 8-hydroxy-7-substituted quinolines as anti-viral agents
    Patent number: 6252080
    Abstract: The present invention provides for 8-hydroxy-7-substituted quinoline compounds such as formula IA These compounds are useful as anti-viral agents. Specifically, these compounds have anti-viral activity against the herpes virus, cytomegalovirus (CMV). Many of these compounds are also active against other herpes viruses, such as the varicella zoster virus, the Epstein-Barr virus, the herpes simplex virus and the human herpes virus type 8 (HHV-8).
    Type: Grant
    Filed: October 22, 1999
    Date of Patent: June 26, 2001
    Assignee: Pharmacia & UpJohn Company
    Inventors: Suvit Thaisrivongs, Oliver Bezencon
  • Quinolinecarboxamides as antiviral agents
    Patent number: 6248739
    Abstract: The present invention provides a compound of formula I which is useful as antiviral agents, in particular, as agents against viruses of the herpes family.
    Type: Grant
    Filed: December 17, 1999
    Date of Patent: June 19, 2001
    Assignee: Pharmacia & Upjohn Company
    Inventors: Steven Ronald Turner, Joseph Walter Strohbach, Suvit Thaisrivongs, Valerie A. Vaillancourt, Mark E. Schnute, John Alan Tucker
  • 4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents
    Patent number: 6248736
    Abstract: The present invention provides a compound of formula I Wherein R1 is C1-7 alkyl, optionally substituted by hydroxy or NR4R5; R2 is C1-7 alkyl substituted by hydroxy or NR4R5; R3 is H, F or C1-7 alkoxy; R4 and R5 together with N are a 5- or 6-membered heterocyclic moiety having 1-3 heteroatoms selected from the group consisting of nitrogen, oxygen and sulfur in which sulfur may be substituted by one (1) or two (2) oxygen atoms; and pharmaceutically acceptable salts thereof Compounds of formula I of the present invention are useful as antiviral agents.
    Type: Grant
    Filed: December 17, 1999
    Date of Patent: June 19, 2001
    Assignee: Pharmacia & Upjohn Company
    Inventors: Steven Ronald Turner, Joseph Walter Strohbach, Suvit Thaisrivongs, Valerie A. Vaillancourt, Mark E. Schnute, Allen Scott
  • Compounds useful to treat retroviral infections
    Patent number: 6169181
    Abstract: The present invention relates to compounds of formula I and II which are pyran-2-ones, 5,6-dihydro-pyran-2-ones, 4-hydroxy-benzopyran-2-ones, 4-hydroxy-cycloalkyl[b]pyran-2-ones, and derivatives thereof, useful for inhibiting a retrovirus in a mammalian cell infected with said retrovirus.
    Type: Grant
    Filed: November 9, 1998
    Date of Patent: January 2, 2001
    Assignee: Pharmacia & Upjohn Company
    Inventors: Karen Rene Romines, Gordon L. Bundy, Theresa M. Schwartz, Ruben A. Tommasi, Joseph W. Strohbach, Steven Ronald Turner, Suvit Thaisrivongs, Paul Adrian Aristoff, Paul D. Johnson, Harvey Irving Skulnick, Louis L. Skaletzky, David John Anderson, Joel Morris, Ronald B. Gammill, George P. Luke
  • 1,3,4-thiadiazoles useful for the treatment of CMV infections
    Patent number: 6150385
    Abstract: The present invention presents novel 1,3,4-thiadiazole derivatives of formula I ##STR1## which have useful antiviral activity against herpes virus, cytomegalovirus (CMV).
    Type: Grant
    Filed: March 16, 1999
    Date of Patent: November 21, 2000
    Assignee: Pharmacia & Upjohn Company
    Inventors: Suvit Thaisrivongs, Steven Ronald Turner
  • 4-hydroxyquinoline-3-carboxamides and hydrazides as antiviral agents
    Patent number: 6093732
    Abstract: The present invention provides 4-hydroxyquinoline-3-carboxamide and hydrazide compounds of formula I ##STR1## These compounds are useful to treat or prevent the herpesviral infections, particularly, human cytomegaloviral infection.
    Type: Grant
    Filed: December 1, 1998
    Date of Patent: July 25, 2000
    Assignee: Pharmacia & Upjohn Company
    Inventors: John Alan Tucker, Valerie A. Vaillancourt, Joseph Walter Strohbach, Karen Rene Romines, Mark E. Schnute, Michele M. Cudahy, Suvit Thaisrivongs, Steven Ronald Turner
  • Substituted tetronic acids useful for treating HIV and other retroviruses
    Patent number: 6060600
    Abstract: This application discloses novel tetronic acids for the treatment of AIDS and other diseases caused by retroviruses.
    Type: Grant
    Filed: September 17, 1997
    Date of Patent: May 9, 2000
    Assignee: Pharmacia & Upjohn Company
    Inventors: Robert A. Chruscial, Linda L. Maggiora, Suvit Thaisrivongs, James M. Tustin, Clark W. Smith, Ruben A. Tommasi, Paul A. Aristoff, Harvey I. Skulnick, W. Jeffrey Howe
  • Substituted tetronic acids useful for treating HIV and other retroviruses
    Patent number: 5977169
    Abstract: This invention comprises novel substituted tetronic acid type compounds, 2, 4(3H, 5H)-furandiones, that are useful for the inhibition of the HIV protease enzyme. The compounds may be useful for the treatment of a person with AIDS or AIDS related diseases. The compounds may be used in the attempt to retard the further replication of any retrovirus containing the aspartyl protease enzyme. Compounds are represented by the formula below.
    Type: Grant
    Filed: July 28, 1997
    Date of Patent: November 2, 1999
    Inventors: Robert A. Chrusciel, Linda L. Maggiora, Suvit Thaisrivongs, James M. Tustin, Clark W. Smith, Ruben A. Tommasi, Paul A. Aristoff, Harvey I. Skulnick, W. Jeffrey Howe, Gordon L. Bundy
  • Pyranone compounds useful to treat retroviral infections
    Patent number: 5852195
    Abstract: The present invention relates to compounds of formulae (I) and (II) which are pyran-2-ones, 5,6-dihydro-pyran-2-ones, 4-hydroxy-benzopyran-2-ones, 4-hydroxy-cycloalkyl?b!pyran-2-ones, and derivatives thereof, useful for inhibiting a retrovirus in a mammalian cell infected with said retrovirus, wherein R.sub.10 and R.sub.20 taken together are formulae (III) and (IV).
    Type: Grant
    Filed: November 4, 1996
    Date of Patent: December 22, 1998
    Assignee: Pharmacia & Upjohn Company
    Inventors: Karen Rene Romines, Gordon L. Bundy, Theresa M. Schwartz, Ruben A. Tommasi, Joseph W. Strohbach, Steven Ronald Turner, Suvit Thaisrivongs, Paul Adrian Aristoff, Paul D. Johnson, Harvey Irving Skulnick, Louis L. Skaletzky, David John Anderson, Joel Morris, Ronald B. Gammill, George P. Luke
  • 4-hydroxy-benzopyran-2-ones and 4-hydroxy-cycloalkyl?b!pyran-2-ones useful to treat retroviral infections
    Patent number: 5686486
    Abstract: The present invention relates to compounds of formula I which are 4-hydroxy-benzopyran-2-ones and 4-hydroxy-cycloalkyl?b!pyran-2-ones useful for inhibiting a retrovirus in a mammalian cell infected with said retrovirus. ##STR1## Wherein R.sub.10 and R.sub.
    Type: Grant
    Filed: August 4, 1995
    Date of Patent: November 11, 1997
    Assignee: Pharmacia & Upjohn Company
    Inventors: Paul Kosta Tomich, Michael John Bohanon, Steven Ronald Turner, Joseph Walter Strohbach, Suvit Thaisrivongs, Richard C. Thomas, Karen Rene Romines, Chih-Ping Yang, Paul Adrian Aristoff, Harvey Irving Skulnick, Paul D. Johnson, Ronald B. Gammill, Qingwei Zhang, Gordon L. Bundy, David John Anderson, Lee S. Banitt